Insulet Corporation (PODD) : Plymouth Lane Capital Management added new position in Insulet Corporation during the most recent quarter end. The investment management firm now holds 110,350 shares of Insulet Corporation which is valued at $4,743,947 , the company said in a statement filed on Aug 11, 2016 with the SEC.Insulet Corporation makes up approximately 5.46% of Plymouth Lane Capital Management’s portfolio.
Other Hedge Funds, Including , Teachers Advisors Inc boosted its stake in PODD in the latest quarter, The investment management firm added 99,780 additional shares and now holds a total of 345,716 shares of Insulet Corporation which is valued at $14,862,331. Insulet Corporation makes up approx 0.02% of Teachers Advisors Inc’s portfolio.Blackrock Institutional Trust Company N.a. boosted its stake in PODD in the latest quarter, The investment management firm added 24,838 additional shares and now holds a total of 1,435,053 shares of Insulet Corporation which is valued at $61,692,928. Insulet Corporation makes up approx 0.01% of Blackrock Institutional Trust Company N.a.’s portfolio.Tower Research Capital (trc) boosted its stake in PODD in the latest quarter, The investment management firm added 1,278 additional shares and now holds a total of 1,769 shares of Insulet Corporation which is valued at $76,049. Insulet Corporation makes up approx 0.01% of Tower Research Capital (trc)’s portfolio. Lebenthal Lisanti Capital Growth sold out all of its stake in PODD during the most recent quarter. The investment firm sold 29,581 shares of PODD which is valued $1,276,716.Shaker Investmentsoh reduced its stake in PODD by selling 8,300 shares or 10.14% in the most recent quarter. The Hedge Fund company now holds 73,540 shares of PODD which is valued at $2,446,676. Insulet Corporation makes up approx 2.17% of Shaker Investmentsoh’s portfolio.
Insulet Corporation closed down -0.26 points or -0.60% at $43.35 with 2,86,357 shares getting traded on Tuesday. Post opening the session at $43.94, the shares hit an intraday low of $43.21 and an intraday high of $43.94 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
On the company’s financial health, Insulet Corporation reported $-0.08 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on Aug 3, 2016. Analyst had a consensus of $-0.17. The company had revenue of $87.33 million for the quarter, compared to analysts expectations of $83.00 million. The company’s revenue was up 44.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.30 EPS.
Many Wall Street Analysts have commented on Insulet Corporation. Company shares were Reiterated by Wedbush on Aug 4, 2016 to “Outperform”, Firm has raised the Price Target to $ 48 from a previous price target of $44 .
Insulet Corporation is a medical device company engaged in the development manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System) an insulin infusion system for people with insulin-dependent diabetes. The Companys principal offices are located in Billerica Massachusetts. Features of the OmniPod System include two-part design no tubing and automated cannula insertion. The OmniPod System consists of two devices that communicate wirelessly: the OmniPod a small lightweight disposable insulin infusion device worn beneath clothing; and the PDM a handheld device much like a personal digital assistant that wirelessly programs the OmniPod with insulin delivery instructions. The OmniPod will operate up to 72 hours (but no more than 80 hours) after it is first activated. The OmniPod System does not have external tubing and features an automated hands-free cannula insertion system.